Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121854826 | 12185482 | 6 | F | 20160708 | 20160316 | 20160713 | EXP | CA-PFIZER INC-2016145185 | PFIZER | 83.00 | YR | F | Y | 0.00000 | 20160713 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121854826 | 12185482 | 1 | SS | ENBREL | ETANERCEPT | 1 | 50 MG, WEEKLY | 0 | 50 | MG | /wk | ||||||||
| 121854826 | 12185482 | 2 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 7.5 TO 12.5 MG, WEEKLY | 11719 | SOLUTION FOR INJECTION | /wk | ||||||||
| 121854826 | 12185482 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Subcutaneous | 7.5 TO 12.5 MG, WEEKLY | 11719 | SOLUTION FOR INJECTION | /wk | ||||||||
| 121854826 | 12185482 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 2.5 G, DAILY | 7073 | 2.5 | G | ||||||||
| 121854826 | 12185482 | 5 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 100 MG, 2X/DAY | 20235 | 100 | MG | BID | |||||||
| 121854826 | 12185482 | 6 | SS | CELEBREX | CELECOXIB | 1 | Oral | UNK | 20998 | CAPSULE, HARD | |||||||||
| 121854826 | 12185482 | 7 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | 400 MG, DAILY | 0 | 400 | MG | |||||||||
| 121854826 | 12185482 | 8 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 121854826 | 12185482 | 9 | SS | FENTANYL. | FENTANYL | 1 | UNK | U | 0 | ||||||||||
| 121854826 | 12185482 | 10 | SS | MYOCHRYSINE | GOLD SODIUM THIOMALATE | 1 | Intramuscular | 50 MG, EVERY 3 WEEKS | 0 | 50 | MG | Q3W | |||||||
| 121854826 | 12185482 | 11 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, MONTHLY | 0 | 750 | MG | /month | |||||||
| 121854826 | 12185482 | 12 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 488 MG, MONTHLY | 0 | 488 | MG | /month | |||||||
| 121854826 | 12185482 | 13 | C | OMEGA-3 FATTY ACIDS | OMEGA-3 FATTY ACIDS | 1 | 1200 MG, 2X/DAY | 0 | 1200 | MG | BID | ||||||||
| 121854826 | 12185482 | 14 | C | MULTIVITAMIN | VITAMINS | 1 | UNK | 0 | |||||||||||
| 121854826 | 12185482 | 15 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | 40 MG, DAILY | 0 | 40 | MG | |||||||||
| 121854826 | 12185482 | 16 | C | DIPHENOXYLATE | DIPHENOXYLATE | 1 | 1 DF (2.5/0.025 MG), DAILY | 0 | 1 | DF | |||||||||
| 121854826 | 12185482 | 17 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 400 IU, DAILY | 0 | 400 | IU | |||||||||
| 121854826 | 12185482 | 18 | C | ACTONEL | RISEDRONATE SODIUM | 1 | 36 MG, WEEKLY | 0 | 36 | MG | /wk | ||||||||
| 121854826 | 12185482 | 19 | C | PREDNISONE. | PREDNISONE | 1 | 5 MG, DAILY | 0 | 5 | MG | |||||||||
| 121854826 | 12185482 | 20 | C | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 750 MG, MONTHLY | 0 | 750 | MG | /month | |||||||
| 121854826 | 12185482 | 21 | C | CALCIUM | CALCIUM | 1 | UNK | 0 | |||||||||||
| 121854826 | 12185482 | 22 | C | FERROUS GLUCONATE | FERROUS GLUCONATE | 1 | 300 MG, DAILY | 0 | 300 | MG | |||||||||
| 121854826 | 12185482 | 23 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 500 MG 2 TABS, 1X/DAY | 0 | 1000 | MG | QD | |||||||
| 121854826 | 12185482 | 24 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 40 MG, 2X/DAY | 0 | 40 | MG | TABLET | BID | |||||||
| 121854826 | 12185482 | 25 | C | TRAZODONE HYDROCHLORIDE. | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, AT BEDTIME | 0 | 50 | MG | QD | |||||||
| 121854826 | 12185482 | 26 | C | NASONEX | MOMETASONE FUROATE | 1 | Nasal | 2 SPRAYS, 2X/DAY | 0 | 2 | DF | BID | |||||||
| 121854826 | 12185482 | 27 | C | NORTRIPTYLINE HYDROCHLORIDE/PERPHENAZINE | 2 | Oral | 10MG TABLETS 1-3 TABLETS EVERY EVENING | 0 | |||||||||||
| 121854826 | 12185482 | 28 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 1 TAB 4-6H AS NEEDED | 0 | 1 | DF | |||||||||
| 121854826 | 12185482 | 29 | C | LOMOTIL | ATROPINE SULFATEDIPHENOXYLATE HYDROCHLORIDE | 1 | 2.5MG 3-4 TIMES/DAY | 0 | 2.5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121854826 | 12185482 | 1 | Rheumatoid arthritis |
| 121854826 | 12185482 | 4 | Rheumatoid arthritis |
| 121854826 | 12185482 | 6 | Arthritis |
| 121854826 | 12185482 | 7 | Rheumatoid arthritis |
| 121854826 | 12185482 | 10 | Rheumatoid arthritis |
| 121854826 | 12185482 | 11 | Rheumatoid arthritis |
| 121854826 | 12185482 | 12 | Rheumatoid arthritis |
| 121854826 | 12185482 | 27 | Sleep disorder |
| 121854826 | 12185482 | 28 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121854826 | 12185482 | HO |
| 121854826 | 12185482 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121854826 | 12185482 | Blood creatinine increased | |
| 121854826 | 12185482 | Blood magnesium increased | |
| 121854826 | 12185482 | Blood potassium increased | |
| 121854826 | 12185482 | Cyst | |
| 121854826 | 12185482 | Deafness neurosensory | |
| 121854826 | 12185482 | Diarrhoea | |
| 121854826 | 12185482 | Drug hypersensitivity | |
| 121854826 | 12185482 | Drug ineffective | |
| 121854826 | 12185482 | Drug intolerance | |
| 121854826 | 12185482 | Dry eye | |
| 121854826 | 12185482 | Epigastric discomfort | |
| 121854826 | 12185482 | Fatigue | |
| 121854826 | 12185482 | Gastrointestinal disorder | |
| 121854826 | 12185482 | Infection | |
| 121854826 | 12185482 | Nausea | |
| 121854826 | 12185482 | Osteoarthritis | |
| 121854826 | 12185482 | Osteopenia | |
| 121854826 | 12185482 | Pleural thickening | |
| 121854826 | 12185482 | Presbyacusis | |
| 121854826 | 12185482 | Renal impairment | |
| 121854826 | 12185482 | Skin lesion | |
| 121854826 | 12185482 | Sleep disorder | |
| 121854826 | 12185482 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121854826 | 12185482 | 1 | 200804 | 201310 | 0 | |
| 121854826 | 12185482 | 2 | 2008 | 2009 | 0 | |
| 121854826 | 12185482 | 3 | 20110516 | 20110913 | 0 | |
| 121854826 | 12185482 | 4 | 200404 | 2008 | 0 | |
| 121854826 | 12185482 | 7 | 2008 | 2008 | 0 | |
| 121854826 | 12185482 | 10 | 200605 | 200802 | 0 | |
| 121854826 | 12185482 | 11 | 20150331 | 20160223 | 0 | |
| 121854826 | 12185482 | 12 | 201310 | 20150303 | 0 |